the aid library

LIST OPTIONS

Filter

1898

Sort by:

Direction:

Download (158)

View PDF (181)

Plan of Action for Cervical Cancer Prevention and Control 2018-2030

Pan American Health Organization (PAHO) (2018) C_WHO

This Plan envisions a future with the elimination of cervical cancer as a public health problem as a result of universal access to sexual health and STI prevention services, HPV vaccines, effective screening and precancer treatment services, treatment of invasive cervical cancer, and palliative care... more

Download (125)

View PDF (211)

Venezuela’s Humanitarian Emergency

Human Rights Watch (2019) C1

Large-Scale UN Response Needed to Address Health and Food Crises This report is based on interviews with more than 150 health care professionals, Venezuelans seeking or in need of medical care who recently arrived in Colombia and Brazil, representatives from international and nongovernmental humani... more

Download (371)

View PDF (670)

Integrating the prevention, treatment and care of mental health conditions and other noncommunicable diseases within health systems

World Health Organization WHO, Regional Office for Europe (2019) C_WHO

Mental health conditions affect one in 10 people at any one time and account for a large proportion of non-fatal disease burden. There is a high degree of comorbidity between mental health conditions such as depression and other noncommunicable diseases (NCDs), including cardiovascular disease, diab... more

Download (1313)

View PDF (1952)

Training of community health workers: Cervical cancer screening and management of cervical pre-cancers

Lakhbir Dhaliwal, Vanita Suri, Reshmi Bagga et al. World Health Organisation (WHO) (2017) C_WHO

Cervical cancer is the second most common cancer among women worldwide and causes a significant number of deaths in the South-East Asia Region. Nearly 200 000 new cases of cervical cancer occurred in SEA Region Member States in 2008, giving an incidence of almost 25 per 100... more

Download (170)

View PDF (241)

Neurological disorders public health challenges

World Health Organization WHO WHO (2006) CC

The Global Burden of Disease (GBD) study, a collaborative endeavour of the World Health Organization (WHO), the World Bank and the Harvard School of Public Health, drew the attention of the international health community to the burden of neurological disorders and many other chronic conditions. T... more

Download (2500)

View PDF (1551)

Reproductive, Maternal, Newborn, and Child Health

Robert E. Black, Ramanan Laxminarayan, Marleen Temmerman; et al. International Bank for Reconstruction and Development The World Bank (2016) CC

Disease Control Priorities –3rdEdition, Volume 2. This book focuses on maternal conditions, childhood illness, and malnutrition. Specifically, the chapters address acute illness and undernutrition in children, principally under age 5. It also covers maternal mortality, morbidity, stillbirth, and ... more

Download (240)

View PDF (331)

Framework for implementing the “End TB Strategy” in the African Region 2016 - 2020

World Health Organization WHO, Regional Office for Africa (2017) C_WHO

Tuberculosis (TB) control in the African Region has evolved since the disease was declared a global emergency by the World Health Organization (WHO) in 1993. Member States have adopted and implemented successive global and regional strategies and resolutions, with demonstrable positive impacts on in... more

Download (193)

View PDF (258)

The Burden of Mental Disorders in the Region of the Americas

World Health Organization, Pan American Health Organization (2018) C_WHO

This report aims to improve the assessment of mental health needs in the Americas by providing an updated and nuanced picture of: (a) the disability resulting from mental, substance use, and specific neurological disorders, plus self-harm, alone and in combination with premature mortality; (b) the i... more

Download (325)

View PDF (609)

South-East Asia Regional response framework for DR-TB, 2017-2021
recommended

World Health Organization (WHO), Regional Office for South-East-Asia (2017) C_WHO

The WHO South-East Asia (‎SEA)‎ Region bears a high burden of tuberculosis (‎TB)‎ and MDR-TB. In 2015, the Region accounted for nearly 200 000 or 35% of the global estimated new RR/MDR-TB cases eligible for treatment. Extensively drug-resistant TB (‎XDRTB)‎ has also been reported from s... more

Download (562)

View PDF (733)

The Diabetic foot. Prevention and management in India Full Background document (Draft)

National Health Mission; Ministry of Health & Social Welfare India (2016) C1

Standard Treatment Guideline

Download (178)

View PDF (234)

Blueprint for a Public Health and Safety Approach to Drug Policy

Tracy Pugh, Julie Netherland, Ruth Finkelstein The New York Academy of Medicine, Drug Policy Alliance (2013) C2

"Some of the problems with our current drug policies stem from the fact that these policies have been largely bifurcated between two different and often contradictory approaches. One treats drug use as a crime that cannot be tolerated and should be punished; the other views addiction as a chronic re... more

Download (298)

View PDF (165)

Annuaire des statistiques sanitaires du Togo, Année 2016

République togolaise, Ministère de la Santé et de la Protection Sociale (2017) C1

L’un des principaux défis auxquels fait face le secteur de la santé au Togo est la mise à la disposition des décideurs, des partenaires et du public des données fiables, pertinentes et à temps opportun. Le présent annuaire des statistiques sanitaires a pour objectif, de contribuer à releve... more

Download (333)

View PDF (456)

Survive, Thrive, Transform — Global Strategy for Women’s, Children’s and Adolescents’ Health (2016–2030)

Joint United Nations Programme on HIVAIDS (UNAIDS) (2018) C1

2018 monitoring report: current status and strategic priorities
The report sets out the status of women’s, children’s and adolescents’ health, and on health systems and social and environmental determinants. Regional dashboards on 16 key indicators highlight where progress is being made o... more

Download (204)

View PDF (291)

Out of the Shadows. Making Mental Health a Global Development Policy
recommended

Seth Mnookin World Bank Group, and World Health Organization WHO (2016) C_WHO

Mental disorders impose an enormous burden on society, accounting for almost one in three years lived with disability globally. •In addition to their health impact, mental disorders cause a significant economic burden due to lost economic output and the link between mental disorders and costly, po... more

Download (156)

View PDF (212)

Haïti : COVID-19 Plan de préparation et de réponse du MSPP, mars 2020

Ministère de la Santè Publique et de la Population Haiti (2020) C1

Le COVID-19 est un nouveau coronavirus, proche de celui du Syndrome Respiratoire Aigu Sévère (SRAS) qui avait été à l’origine d’une épidémie meurtrière en 2003. L’infection par ce nouveau coronavirus se manifeste le plus souvent par une fièvre et des signes respiratoires pouvant se co... more

Download (189)

View PDF (266)

Violence and injuries in Europe: burden, prevention and priorities for action

World Health Organization WHO, Regional Office of Europe (2020) C_WHO

The WHO Global Health Estimates show that nearly half a million deaths (493 471) occurred in the WHO European Region due to violence and injuries in 2016. This represents a decline of 29% from 2000. Injuries account for 5.3% of all deaths and 9.6 of all years of life lost. They are a leading cause o... more

Download (128)

View PDF (154)

Readiness for influenza during the COVID-19 pandemic

World Health Organization WHO (2020) C_WHO

5 Nov. 2020 The policy brief provides a concise summary of information and considerations to ensure optimal management of influenza during the COVID-19 pandemic. It includes a list of technical guidance and other resources to assist policy makers with monitoring the situation, preventing seasonal i... more

Download (65)

View PDF (416)

Disruption in essential health services in Mexico during COVID-19: an interrupted time series analysis of health information system data

Doubova SV, Leslie HH, Kruk ME, et al. BMJ Global Health (2021) CC

INTRODUCTION: The COVID-19 pandemic has disrupted health systems around the world. The objectives of this study are to estimate the overall effect of the pandemic on essential health service use and outcomes in Mexico, describe observed and predicted trends in services over 24 months, and to estimat... more

Download (238)

View PDF (230)

Standard Operating Procedures - Adherence Guidelines for HIV, TB and NCDs: Training Course for Health Care Workers - Faciliation Guide
recommended

National Department of Health, South Africa (2020) C1

The target audience for this training course is non-clinicians such as Home Based Carers, Community Caregivers, Youth Care Workers, Peer educators, Community Health Workers etc. primarily those who will be providing adherence counselling to clients with HIV, TB, Hypertension and Diabetes. This group... more

Download (245)

View PDF (329)

Therapeutics and COVID-19 (Living Guideline, 10 November 2023)

World Health Organization WHO (2023) C_WHO

WHO has updated its guidelines for COVID-19 therapeutics, with revised recommendations for patients with non-severe COVID-19. This is the 13th update to these guidelines. Updated risk rates for hospital admission in patients with non-severe COVID-19 The guidance includes updated risk rates for... hospital admission in patients with non-severe COVID-19. The current COVID-19 virus variants tend to cause less severe disease while immunity levels are higher due to vaccination, leading to lower risks of severe illness and death for most patients. This update includes new baseline risk estimates for hospital admission in patients with non-severe COVID-19. The new ‘moderate risk’ category now includes people previously considered to be high risk including older people and/or those with chronic conditions, disabilities, and comorbidities of chronic disease. The updated risk estimates will assist healthcare professionals to identify individuals at high, moderate or low risk of hospital admission, and to tailor treatment according to WHO guidelines: **High: **People who are immunosuppressed remain at higher risk if they contract COVID-19, with an estimated hospitalization rate of 6%. **Moderate: **People over 65 years old, those with conditions like obesity, diabetes and/or chronic conditions including chronic obstructive pulmonary disease, kidney or liver disease, cancer, people with disabilities and those with comorbidities of chronic disease are at moderate risk, with an estimated hospitalization rate of 3%. Low: Those who are not in the high or moderate risk categories are at low risk of hospitalization (0.5%). Most people are low risk. Review of COVID-19 treatments for people with non-severe COVID-19 WHO continues to strongly recommend nirmatrelvir-ritonavir (also known by its brand name ‘Paxlovid’) for people at high-risk and moderate risk of hospitalization. The recommendations state that nirmatrelvir-ritonavir is considered the best choice for most eligible patients, given its therapeutic benefits, ease of administration and fewer concerns about potential harms. Nirmatrelvir-ritonavir was first recommended by WHO in April 2022. If nirmatrelvir-ritonavir is not available to patients at high-risk of hospitalization, WHO suggests the use of molnupiravir or remdesivir instead. WHO suggests against the use of molnupiravir and remdesivir for patients at moderate risk, judging the potential harms to outweigh the limited benefits in patients at moderate risk of hospital admission. For people at low risk of hospitalization, WHO does not recommend any antiviral therapy. Symptoms like fever and pain can continue to be managed with analgesics like paracetamol. WHO also recommends against use of a new antiviral (VV116) for patients, except in clinical trials. The update also includes a strong recommendation against the use of ivermectin for patients with non-severe COVID-19. WHO continues to advise that in patients with severe or critical COVID-19, ivermectin should only be used in clinical trials. more

South-East Asia Regional response framework for DR-TB, 2017-2021 recommended

Out of the Shadows. Making Mental Health a Global Development Policy recommended

Standard Operating Procedures - Adherence Guidelines for HIV, TB and NCDs: Training Course for Health Care Workers - Faciliation Guide recommended

South-East Asia Regional response framework for DR-TB, 2017-2021
recommended

Out of the Shadows. Making Mental Health a Global Development Policy
recommended

Standard Operating Procedures - Adherence Guidelines for HIV, TB and NCDs: Training Course for Health Care Workers - Faciliation Guide
recommended